As of 2025-07-09, the Relative Valuation of Agile Therapeutics Inc (AGRX) is (17.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.60 USD, the upside of Agile Therapeutics Inc based on Relative Valuation is -3057.2%.
The range of the Relative Valuation is (17.82) - (17.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 18.9x | 18.4x |
| Forward P/E multiples | 19.5x - 22.0x | 20.5x |
| Fair Price | (17.82) - (17.34) | (17.81) |
| Upside | -3058.7% - -2979.7% | -3057.2% |
| Date | P/E |